Literature DB >> 28532079

Nerve growth factor-loaded heparinized cationic solid lipid nanoparticles for regulating membrane charge of induced pluripotent stem cells during differentiation.

Yung-Chih Kuo1, Rajendiran Rajesh2.   

Abstract

Nerve growth factor (NGF)-loaded heparinized cationic solid lipid nanoparticles (NGF-loaded HCSLNs) were developed using heparin-stearic acid conjugate, cacao butter, cholesterol, stearylamine (SA), and esterquat 1 (EQ 1). The effect of cationic lipids and lipid matrix composition on the particle size, particle structure, surface molecular composition, chemical structure, electrophoretic mobility, and zeta potential of HCSLNs was investigated. The effect of HCSLNs on the membrane charge of induced pluripotent stem cells (iPSCs) was also studied. The results indicated that the average diameter of HCSLNs was 90-240nm and the particle size of HCSLNs with EQ 1 was smaller than that with SA. The zeta potential and electrophoresis analysis showed that HCSLNs with SA had a positively charged potential and HCSLNs with EQ 1 had a negatively charged potential at pH7.4. The high-resolution transmission electron microscope confirmed the loading of NGF on the surface of HCSLNs. Differentiation of iPSCs using NGF-loaded HCSLNs with EQ 1 exhibited higher absolute values of the electrophoretic mobility and zeta potential than differentiation using NGF-loaded HCSLNs with SA. The immunochemical staining of neuronal nuclei revealed that NGF-loaded HCSLNs can be used for differentiation of iPSCs into neurons. NGF-loaded HCSLNs with EQ 1 had higher viability of iPSCs than NGF-loaded HCSLNs with SA. NGF-loaded HCSLNs with EQ 1 may be promising formulation to regulate the membrane charge of iPSCs during neuronal differentiation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Differentiation; Electrophoretic mobility; Heparinized cationic solid lipid nanoparticle; Induced pluripotent stem cell; Nerve growth factor; Neuron

Mesh:

Substances:

Year:  2017        PMID: 28532079     DOI: 10.1016/j.msec.2017.03.303

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  6 in total

Review 1.  Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders.

Authors:  Caroline Vissers; Guo-Li Ming; Hongjun Song
Journal:  Adv Drug Deliv Rev       Date:  2019-02-21       Impact factor: 15.470

Review 2.  The effects of combination therapy by solid lipid nanoparticle and dental stem cells on different degenerative diseases.

Authors:  Farideh Kamarehei
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

Review 3.  Impact of nanoparticles on neuron biology: current research trends.

Authors:  Firdos Alam Khan; Dana Almohazey; Munthar Alomari; Sarah Ameen Almofty
Journal:  Int J Nanomedicine       Date:  2018-05-09

Review 4.  Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease.

Authors:  Govindarajan Karthivashan; Palanivel Ganesan; Shin-Young Park; Joon-Soo Kim; Dong-Kug Choi
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

Review 5.  Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis.

Authors:  G Y Wang; S L Rayner; R Chung; B Y Shi; X J Liang
Journal:  Mater Today Bio       Date:  2020-05-04

Review 6.  Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview.

Authors:  Farzane Sivandzade; Luca Cucullo
Journal:  Int J Mol Sci       Date:  2021-02-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.